Fatal herpes simplex virus hepatitis complicating chemotherapy with weekly docetaxel.
作者信息
Hofer S, Hunziker S, Tornillo L, Ludwig C U
出版信息
Ann Oncol. 2003 Feb;14(2):340. doi: 10.1093/annonc/mdg052.
PMID:12562665
Abstract
摘要
相似文献
1
Fatal herpes simplex virus hepatitis complicating chemotherapy with weekly docetaxel.
Ann Oncol. 2003 Feb;14(2):340. doi: 10.1093/annonc/mdg052.
2
[Low-dose weekly administration of docetaxel for metastatic breast cancer].
Gan To Kagaku Ryoho. 1999 Jun;26(7):995-9.
3
Reversible life-threatening encephalopathy in the absence of hepatic failure following conventional doses of docetaxel.
Clin Oncol (R Coll Radiol). 2003 May;15(3):160-1. doi: 10.1053/clon.2002.0191.
4
Docetaxel. A review of its role in breast cancer treatment.
Am J Clin Oncol. 1997 Aug;20(4):429-32. doi: 10.1097/00000421-199708000-00023.
5
[Fulminant hepatocellular necrosis following administration of docetaxel].
Presse Med. 2001 Apr 7;30(13):634.
6
Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
Clin Oncol (R Coll Radiol). 2000;12(4):272-3.
7
[Current developments in use of docetaxel (taxotere) in gynecologic oncology].
Med Klin (Munich). 1998 Sep 15;93 Suppl 3:4-15. doi: 10.1007/BF03042002.
8
[Docetaxel hydrate for treatment of advanced breast cancers].
Nihon Rinsho. 2000 Apr;58 Suppl:254-8.
9
Taxane-based therapy for breast cancer: combination or sequential therapy?
Cancer Invest. 2000;18(5):498-500. doi: 10.3109/07357900009032823.
10
Successful treatment of thrombocytopenia due to marrow metastases of breast cancer with weekly docetaxel.
J Natl Cancer Inst. 2003 Jun 4;95(11):831-2. doi: 10.1093/jnci/95.11.831-a.
Zotero 插件